These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 14678718)

  • 21. Atopic dermatitis management with tacrolimus ointment (Protopic).
    Kapp A; Allen BR; Reitamo S
    J Dermatolog Treat; 2003; 14(Suppl 1):5-16. PubMed ID: 14522634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer concerns with topical immunomodulators in atopic dermatitis: overview of data and recommendations to clinicians.
    Patel TS; Greer SC; Skinner RB
    Am J Clin Dermatol; 2007; 8(4):189-94. PubMed ID: 17645374
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of sequential applications of topical tacrolimus and topical corticosteroids in the treatment of pediatric atopic dermatitis: an open-label pilot study.
    Kubota Y; Yoneda K; Nakai K; Katsuura J; Moriue T; Matsuoka Y; Miyamoto I; Ohya Y
    J Am Acad Dermatol; 2009 Feb; 60(2):212-7. PubMed ID: 19027990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Topical noncorticosteroid immunomodulation in the treatment of atopic dermatitis.
    Reitamo S; Remitz A; Kyllönen H; Saarikko J
    Am J Clin Dermatol; 2002; 3(6):381-8. PubMed ID: 12113647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pimecrolimus cream and Tacrolimus ointment in the treatment of atopic dermatitis: a pilot study on patient preference.
    Onumah N; Kircik L
    J Drugs Dermatol; 2013 Oct; 12(10):1145-8. PubMed ID: 24085050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Eczema drugs tacrolimus (Protopic) and pimecrolimus (Elidel): cancer concerns.
    Wooltorton E
    CMAJ; 2005 Apr; 172(9):1179-80. PubMed ID: 15817641
    [No Abstract]   [Full Text] [Related]  

  • 27. The role of pimecrolimus cream 1% (Elidel)) in managing adult atopic eczema.
    Meurer M; Lubbe J; Kapp A; Schneider D
    Dermatology; 2007; 215 Suppl 1():18-26. PubMed ID: 18174690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Eczema molluscatum in tacrolimus treated atopic dermatitis.
    Wetzel S; Wollenberg A
    Eur J Dermatol; 2004; 14(1):73-4. PubMed ID: 14965804
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pimecrolimus: a review of its use in atopic dermatitis.
    Wellington K; Noble S
    Am J Clin Dermatol; 2004; 5(6):479-95. PubMed ID: 15663345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical management of atopic eczema with pimecrolimus cream 1% (Elidel) in paediatric patients.
    Eichenfield LF; Thaci D; de Prost Y; Puig L; Paul C
    Dermatology; 2007; 215 Suppl 1():3-17. PubMed ID: 18174689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The treatment of facial atopic dermatitis in children who are intolerant of, or dependent on, topical corticosteroids: a randomized, controlled clinical trial.
    Hoeger PH; Lee KH; Jautova J; Wohlrab J; Guettner A; Mizutani G; Hultsch T
    Br J Dermatol; 2009 Feb; 160(2):415-22. PubMed ID: 19067708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-steroidal topical immunomodulators provide skin-selective, self-limiting treatment in atopic dermatitis.
    Bos JD
    Eur J Dermatol; 2003; 13(5):455-61. PubMed ID: 14693489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A bilateral comparison study of pimecrolimus cream 1% and a topical medical device cream in the treatment of patients with atopic dermatitis.
    Emer JJ; Frankel A; Sohn A; Lebwohl M
    J Drugs Dermatol; 2011 Jul; 10(7):735-43. PubMed ID: 21720655
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized controlled trial of pimecrolimus cream 1% in adolescents and adults with head and neck atopic dermatitis and intolerant of, or dependent on, topical corticosteroids.
    Murrell DF; Calvieri S; Ortonne JP; Ho VC; Weise-Riccardi S; Barbier N; Paul CF
    Br J Dermatol; 2007 Nov; 157(5):954-9. PubMed ID: 17935515
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elidel (pimecrolimus) cream 1%: a nonsteroidal topical agent for the treatment of atopic dermatitis.
    Eichenfield LF; Beck L
    J Allergy Clin Immunol; 2003 May; 111(5):1153-68. PubMed ID: 12743593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topical calcineurin inhibitors in the treatment of atopic dermatitis - an update on safety issues.
    Czarnecka-Operacz M; Jenerowicz D
    J Dtsch Dermatol Ges; 2012 Mar; 10(3):167-72. PubMed ID: 21974750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and efficacy of topical calcineurin inhibitors in the treatment of childhood atopic dermatitis.
    Breuer K; Werfel T; Kapp A
    Am J Clin Dermatol; 2005; 6(2):65-77. PubMed ID: 15799678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of pimecrolimus cream in disorders other than atopic dermatitis.
    Day I; Lin AN
    J Cutan Med Surg; 2008; 12(1):17-26. PubMed ID: 18258153
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of paediatric atopic dermatitis with pimecrolimus (Elidel, SDZ ASM 981): impact on quality of life and health-related quality of life.
    McKenna SP; Whalley D; de Prost Y; Staab D; Huels J; Paul CF; van Assche D
    J Eur Acad Dermatol Venereol; 2006 Mar; 20(3):248-54. PubMed ID: 16503881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children.
    Wahn U; Bos JD; Goodfield M; Caputo R; Papp K; Manjra A; Dobozy A; Paul C; Molloy S; Hultsch T; Graeber M; Cherill R; de Prost Y;
    Pediatrics; 2002 Jul; 110(1 Pt 1):e2. PubMed ID: 12093983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.